Toggle navigation
Home
Search
Services
Blog
Contact
About
Rand. Clinical Trial of High Dose Immunoblative Thera-264992243
Johns Hopkins University, Baltimore, MD, United States
Search grants from Johns Hopkins University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Computationally Designed Heparan Sulfates and Pathophysiology
Training Program
Molecular Mechanisms of PARP-Dependent Cell Death in Stroke
Novel Intracellular Sensor for Cyclic Amp
Prevention of Disease by Immunologic Agents in Mice
Recently added grants:
BLR&D Research Career Scientist Application
BLR&D Research Career Scientist Award
BLR&D Research Career Scientist Renewal Award Application
BLR&D Research Career Scientist Award Application
BLR&D Research Career Scientist Award Application
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research and Development Contracts (N01)
Project #
N01AR092243-006
Application #
6688736
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Related projects
NIH 2003
N01 AR
Rand. Clinical Trial of High Dose Immunoblative Thera-264992243
/ Johns Hopkins University
NIH 2002
N01 AR
Rand. Clinical Trial of High Dose Immunoblative Thera-264992243
/ Johns Hopkins University
NIH 2000
N01 AR
Rand. Clinical Trial of High Dose Immunoblative Thera
Petri, Michelle A. / Johns Hopkins University
$183,570
NIH 1999
N01 AR
Rand. Clinical Trial of High Dose Immunoblative Thera
Petri, Michelle A. / Johns Hopkins University
Publications
Petri, Michelle; Brodsky, Robert A; Jones, Richard J et al.
(2010)
High-dose cyclophosphamide versus monthly intravenous cyclophosphamide for systemic lupus erythematosus: a prospective randomized trial.
Arthritis Rheum 62:1487-93
Comments
Be the first to comment on this grant